ES2065951T3 - Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida. - Google Patents

Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.

Info

Publication number
ES2065951T3
ES2065951T3 ES89113351T ES89113351T ES2065951T3 ES 2065951 T3 ES2065951 T3 ES 2065951T3 ES 89113351 T ES89113351 T ES 89113351T ES 89113351 T ES89113351 T ES 89113351T ES 2065951 T3 ES2065951 T3 ES 2065951T3
Authority
ES
Spain
Prior art keywords
aids
treatment
prolylendopeptidase
inhibitor
pep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113351T
Other languages
English (en)
Inventor
Kiyoshi Takatsuki
Toshio Hattori
Daisuke Tsuru
Tadashi Yoshimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of ES2065951T3 publication Critical patent/ES2065951T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBEN AGENTES PREVENTIVOS Y CURATIVOS PARA EL SINDROME DE INMUNO DEFICIENCIA ADQUIRIDA Y AGENTES ANTI-HIV. CONTIENEN UN INHIBIDOR PROLILENDOPEPTIDASA COMO UN INGREDIENTE EFECTIVO.
ES89113351T 1988-07-25 1989-07-20 Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida. Expired - Lifetime ES2065951T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18525988 1988-07-25

Publications (1)

Publication Number Publication Date
ES2065951T3 true ES2065951T3 (es) 1995-03-01

Family

ID=16167692

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113351T Expired - Lifetime ES2065951T3 (es) 1988-07-25 1989-07-20 Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.

Country Status (7)

Country Link
EP (1) EP0355409B1 (es)
JP (1) JPH02124818A (es)
KR (1) KR0124028B1 (es)
AT (1) ATE113843T1 (es)
CA (1) CA1335079C (es)
DE (1) DE68919301T2 (es)
ES (1) ES2065951T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089890A1 (en) * 1991-06-20 1992-12-21 Makoto Yoshihama Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors
HUP9700442A1 (hu) * 1997-02-14 1999-09-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Gyűrűs amidszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CN115778946B (zh) * 2022-11-04 2023-08-01 中国农业科学院兰州兽医研究所 化合物zpp在制备抗病毒药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188317A (ja) * 1984-03-09 1985-09-25 Yakult Honsha Co Ltd 抗健忘症剤

Also Published As

Publication number Publication date
DE68919301T2 (de) 1995-06-08
JPH02124818A (ja) 1990-05-14
KR900001368A (ko) 1990-02-27
EP0355409B1 (en) 1994-11-09
CA1335079C (en) 1995-04-04
EP0355409A2 (en) 1990-02-28
KR0124028B1 (ko) 1997-11-27
DE68919301D1 (de) 1994-12-15
EP0355409A3 (en) 1991-04-03
ATE113843T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
ES2132201T3 (es) Inhibidores de la hiv proteasa utiles en el tratamiento del sida.
DE69228106D1 (de) HIV-Protease-Inhibitoren
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE245977T1 (de) Therapeutische substituierte guanidine
RU95107403A (ru) Бензоксазиноновые соединения, фармацевтические композиции, способы ингибирования обратной транскритазы, профилактики или лечения, синергистические комбинации и способ получения (-)-6-хлор-4-циклопропилэтинил-4-трифторметил-1,4-дигидро-2н-3,1-бензоксазин-2-она
FI834320A (fi) Peptidfoereningar.
ES2174921T3 (es) Inhibidores de la proteasa del vih.
DE69104615D1 (de) Diphenylpiperazinderivat.
ES2101252T3 (es) Inhibidores de la proteasa del hiv utiles para el tratamiento del sida.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
MX9302681A (es) Nuevas quinazolinas como inhibidores de transcriptasa inversa hiv.
CO4130200A1 (es) Inhibidores de proteasa del hiv utiles en el tratamiento del sida
ES2096874T3 (es) Inhibidor de la proteasa de hiv util para el tratamiento del sida.
ES2065951T3 (es) Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.
DE68900760D1 (de) Virushemmende nukleosidmischung.
ATE91415T1 (de) Phenoxy- und phenylthio-, amino-substituierte benzocyclo-alkan-derivate bei der behandlung und verhuetung von arzneimittelresistenten protozoen- infektionen.
ATE383161T1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
RO95162B (ro) Compozitie erbicida sinergetica
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
ES2102370T3 (es) Composicion antiparasitaria para uso animal.
KR900002787A (ko) 인체 후천성 면역부전증후군 바이러스 감염 저해제
MX9206294A (es) Inhibidores de proteasa de vih
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 355409

Country of ref document: ES